Latest Articles
Worcester woman says endometriosis symptoms were not taken seriously - BBC
Worcester woman says endometriosis symptoms were not taken seriously BBC
Published: Dec. 11, 2024, 4:35 p.m.
Worcester woman says endometriosis symptoms were not taken seriously - feeds.bbci.co.uk
Worcester woman says endometriosis symptoms were not taken seriously feeds.bbci.co.uk
Published: Dec. 11, 2024, 4:35 p.m.
Endometrial Cancer Market Diagnosing and Treating a Growing - openPR
Endometrial Cancer Market Diagnosing and Treating a Growing openPR
Published: Dec. 11, 2024, 10:11 a.m.
Primary Umbilical Endometriosis (Villar’s Nodule): A Case Report - Dove Medical Press
Primary Umbilical Endometriosis (Villar’s Nodule): A Case Report Dove Medical Press
Published: Dec. 11, 2024, 7:09 a.m.
Expert Shares 5 Ways To Know If Your Menstrual Cramps Have Advanced Towards Endometriosis - Onlymyhealth
Expert Shares 5 Ways To Know If Your Menstrual Cramps Have Advanced Towards Endometriosis Onlymyhealth
Published: Dec. 11, 2024, 6:07 a.m.
Monash Endometriosis research receives support from Spanish media fundraiser - Monash University
Monash Endometriosis research receives support from Spanish media fundraiser Monash University
Published: Dec. 11, 2024, 2:56 a.m.
Addressing mental health risks in endometriosis patients - Contemporary Obgyn
Addressing mental health risks in endometriosis patients Contemporary Obgyn
Published: Dec. 10, 2024, 10:07 p.m.
Early Recurrence After Surgery in FIGO 2023 Stage I-III Endometrial Cancer: Characteristics and risk factors - Frontiers
Early Recurrence After Surgery in FIGO 2023 Stage I-III Endometrial Cancer: Characteristics and risk factors Frontiers
Published: Dec. 10, 2024, 4:36 p.m.
Endometriosis framework pushed back - Newstalk
Endometriosis framework pushed back Newstalk
Published: Dec. 10, 2024, 2:27 p.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace
Published: Dec. 10, 2024, 12:23 p.m.
Link copied to clipboard!